Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2011
  • Online publication date: July 2011

Chapter 24 - Laboratory-based tests of blood clotting

References

1. Rinder CS. Hematologic effects and coagulopathy. In Gravlee GP, Davis RF, Stammers AH, Ungerleider RM, eds. Cardiopulmonary Bypass: Principles and Practice, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2008, pp. 439–58.
2. Schmaier AH, Thornburg CD, Pipe SW. Coagulation and fibrinolysis. In Miller JL, ed. McPherson & Pincus: Henry's Clinical Diagnosis and Management by Laboratory Methods, 21st ed. Philadelphia: W. B. Saunders Elsevier, 2006, accessed via www.mdconsult.com, 2009, Elsevier Inc.
3. Horrow JC, Mueksch JN. Coagulation testing. In Gravlee GP, Davis RF, Stammers AH, Ungerleider RM, eds. Cardiopulmonary Bypass: Principles and Practice, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2008, pp. 459–71.
4. Appendix: Reference intervals and laboratory values. In Goldman L, Ausiello D, eds. Cecil Medicine, 23rd ed. Philadelphia: Saunders Elsevier, 2008, accessed via www.mdconsult.com, 2009, Elsevier Inc.
5. Fink LM, Marlar RA, Miller JL. Antithrombotic therapy. In Miller JL, ed. McPherson & Pincus: Henry's Clinical Diagnosis and Management by Laboratory Methods, 21st ed. Philadelphia: W. B. Saunders Elsevier, 2006, accessed via www.mdconsult.com, 2009, Elsevier Inc.
6. Counts RB, Haish C, Simon TL, et al. Hemostasis in massively transfused trauma patients. Ann Surg 1979;190:91–99.
7. Mannucci PM, Federici AB, Sirchia G. Hemostasis during massive blood replacement: a study of 172 cases. Vox Sang 1982;42:113–23.
8. Miller RD, Robbins TO, Tong MJ, Barton SL. Coagulation defects associated with massive blood transfusions. Ann Surg 1971;174:795–801.
9. Harker LA, Malpass TW, Branson HE, Hessel EA 2nd. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective α-granule release. Blood 1980;56:824–34.
10. Slaughter TF, Sreeram G, Sharma AD, El-Moalem H, et al. Reversible shear –medicated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagul Fibrinolysis 2001;12:85–93.
11. Reed RL III, Heimbach DM, Counts RB, Baron L, et al. Prophylactic platelet administration during massive transfusion: a prospective, randomized, double-blind clinical study. Ann Surg 1986;203:40–48.
12. Hayem G. Du sang et de ses altérations anatomiques. G. Masson, 1889.
13. Hett DA, Walker D, Pilkington SN, Smith DC. Sonoclot analysis. Br J Anaesth 1995;75:771–6.
14. Koffmann K. Der Koaguloviskosimeter mit spezieller Beruecksichtigung seiner klinischen verwendbarkeit fuer gerinnungsestimmungen des Blutes. Zeitschrift Klinische Medizin 1910;59:415–21.
15. Hartert H. Thrombelastography, a method for physical analysis of blood coagulation. Z Gesamte Exp Med 1951;117:189–203.
16. Hartert H. Blutgerninnungstudien mit der thromboeslastographic, einen neven untersuchingsver fahren. Klin Wochenschr 1948;26:577–83.
17. von Kaulla KN, Ostendorf P, von Kaulla E. The impedance machine: a new bedside coagulation recording device. J Med 1975;6:73–88.
18. Sienco Inc. The Sonoclot Coagulation and Platelet Function Analyzer Owners Manual. 1996–2006.
19. Ganter MT, Hofer CK. Intensive care medicine; point-of-care coagulation monitoring: current status of viscoelastic techniques. In Vincent J-L, ed. Intensive Care Medicine Annual Update 2007, Springer Berlin/Heidelberg, 2007, pp. 834–46.
20. Ganter MT, Monn A, Tavakoli R, et al. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot. Eur J Cardiothorac Surg 2006;30:278–84.
21. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008;106:1366–75.
22. Tanaka KA, Szlam F, Sun HY, Taketomi T, Levy JH. Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin. Anesth Analg 2007;105:933–9.
23. Miyashita T, Kuro M. Evaluation of platelet function by Sonoclot analysis compared with other hemostatic variables in cardiac surgery. Anesth Analg 1998;87:1228–33.
24. Chapin JW, Becker GL, Hulbert BJ, et al. Comparison of thromboelastograph and Sonoclot coagulation analyzer for assessing coagulation status during orthotopic liver transplantation. Transplant Proc 1989;21:3539.
25. Tuman KJ, Spiess BD, McCarthy RJ, Ivankovich AD. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Anesth Analg 1989;69:69–75.
26. Ganter MT, Dalbert S, Graves K, Klaghofer R, Zollinger A, Hofer CK. Monitoring activated clotting time for combined heparin and aprotinin application: an in vitro evaluation of a new aprotinin-insensitive test using Sonoclot. Anesth Analg 2005;101:308–14.
27. Tucci MA, Ganter MT, Hamiel CR, Klaghofer R, Zollinger A, Hofer CK. Platelet function monitoring with the Sonoclot analyzer after in vitro tirofiban and heparin administration. J Thorac Cardiovasc Surg 2006;131:1314–22.
28. Ganter MT, Monn A, Tavakoli R, Klaghofer R, Zollinger A, Hofer CK. Kaolin-based activated coagulation time measured by Sonoclot in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2007;21:524–8.
29. Dalbert S, Ganter MT, Furrer L, Klaghofer R, Zollinger A, Hofer CK. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices. Acta Anaesthesiol Scand 2006;50:461–8.
30. Sugiura K, Ikeda Y, Ono F, Watanabe K, Ando Y. Detection of hypercoagulability by the measurement of the dynamic loss modulus of clotting blood. Thromb Res 1982;27:161–6.
31. Stern MP, DeVos-Doyle K, Viguera MG, Lajos TZ. Evaluation of post-cardiopulmonary bypass Sonoclot signatures in patients taking nonsteroidal anti-inflammatory drugs. J Cardiothorac Anesth 1989;3:730–3.
32. Saleem A, Blifeld C, Saleh SA, et al. Viscoelastic measurement of clot formation: a new test of platelet function. Ann Clin Lab Sci 1983;13:115–24.
33. Nuttall GA, Oliver WC, Ereth MH, Santrach PJ. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997;11:815–23.
34. McKenzie ME, Gurbel PA, Levine DJ, Serebruany VL. Clinical utility of available methods for determining platelet function. Cardiology 1999;92:240–7.
35. Horlocker TT, Schroeder DR. Effect of age, gender, and platelet count on Sonoclot coagulation analysis in patients undergoing orthopedic operations. Mayo Clin Proc 1997;72:214–9.
36. Ekback G, Carlsson O, Schott U. Sonoclot coagulation analysis: a study of test variability. J Cardiothorac Vasc Anesth 1999;13:393–7.
37. Kang YG, Martin DJ, Marquez J, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985;64:888–96.
38. Ganter MT, Schmuck S, Hamiel CR, et al. Monitoring recombinant factor VIIa treatment: efficacy depends on high levels of fibrinogen in a model of severe dilutional coagulopathy. J Cardiothorac Vasc Anesth 2008;22:675–80.
39. Ferraris VA, Ferraris SP, Saha SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007;83(5 Suppl):S27–S86.
40. Spiess BD, Tuman KJ, McCarthy RJ, et al. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit 1987;3:25–30.
41. Camenzind V, Bombeli T, Seifert B, et al. Citrate storage affects thrombelastograph analysis. Anesthesiology 2000;92:1242–9.
42. Chandler WL. The thromboelastography and the thromboelastograph technique. Semin Thromb Hemost 1995;21:1–6.
43. Bowbrick VA, Mikhailidis DP, Stansby G. The use of citrated whole blood in thromboelastography. Anesth Analg 2000;90:1086–8.
44. Yamakage M, Tsujiguchi N, Kohro S et al. The usefulness of celite-activated thromboelastography for evaluation of fibrinolysis. Can J Anaesth 1998;45:993–6.
45. Dietrich W, Jochum M. Effect of celite and kaolin on activated clotting time in the presence of aprotinin: activated clotting time is reduced by binding of aprotinin to kaolin. J Thorac Cardiovasc Surg 1995;109:177–8.
46. Johansson PI, Bochsen L, Andersen S, Viuff D. Investigation of the effect of kaolin and tissue-factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography. Transfusion 2008;48:2377–83.
47. Khurana S, Mattson JC, Westley S, et al. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 1997;130:401–11.
48. Boisclair MD, Lane DA, Philippou H, et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 1993;82:3350–7.
49. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001;86:575–8.
50. Tuman KJ, McCarthy RJ, Djuric M, et al. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay. J Cardiothorac Vasc Anesth 1994;8:144–9.
51. Despotis GJ, Summerfield AL, Joist JH, et al. In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients. Anesth Analg 1994;79:670–4.
52. Gottumukkala VN, Sharma SK, Philip J. Assessing platelet and fibrinogen contribution to clot strength using modified thromboelastography in pregnant women. Anesth Analg 1999;89:1453–5.
53. Cammerer U, Dietrich W, Rampf T, et al. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003;96:51–57.
54. Papatheodoridis GV, Patch D, Webster GJ, et al. Infection and hemostasis in decompensated cirrhosis: a prospective study using thrombelastography. Hepatology 1999;29:1085–90.
55. Senzolo M, Cholongitas E, Thalheimer U, et al. Heparin-like effect in liver disease and liver transplantation. Clin Liver Dis 2009;13:43–53.
56. Agarwal S, Senzolo M, Melikian C, et al. The prevalence of a heparin-like effect shown on the thromboelastograph in patients undergoing liver transplantation. Liver Transpl 2008;14:855–66.
57. Hendriks HG, Meijer K, de Wolf JT, et al. Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation. Blood Coagul Fibrinolysis 2002;13:309–13.
58. Coakley M, Reddy K, Mackie I, Mallett S. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth 2006;20:548–53.
59. Gillies BS. Thromboelastography and liver transplantation. Semin Thromb Hemost 1995;21Suppl 4:45–49.
60. Schumann R. Intraoperative resource utilization in anesthesia for liver transplantation in the United States: a survey. Anesth Analg 2003;97:21–28.
61. Fuchs RJ, Levin J, Tadel M, Merritt W. Perioperative coagulation management in a patient with afibrinogenemia undergoing liver transplantation. Liver Transpl 2007;13:752–6.
62. Stahl RL, Duncan A, Hooks MA, et al. A hypercoagulable state follows orthotopic liver transplantation. Hepatology 1990;12:553–8.
63. Cerutti E, Stratta C, Romagnoli R, et al. Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl 2004;10:289–94.
64. Wilson D, Cooke EA, McNally MA, et al. Changes in coagulability as measured by thrombelastography following surgery for proximal femoral fracture. Injury 2001;32:765–70.
65. Hsu HW, Huang CH, Chang Y et al. Perioperative alterations of the thromboelastography in patients receiving one-stage bilateral total knee arthroplasty. Acta Anaesthesiol Sin 1996;34:129–34.
66. Mittermayr M, Streif W, Haas T et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 2007;105:905–17.
67. Kaufmann CR, Dwyer KM, Crews JD, et al. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997;42:716–22.
68. Watts DD, Trask A, Soeken K, et al. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 1998;44:846–54.
69. Sharma SK, Philip J, Wiley J. Thromboelastographic changes in healthy parturients and postpartum women. Anesth Analg 1997;85:94–98.
70. Sharma SK, Philip J, Whitten CW, et al. Assessment of changes in coagulation in parturients with preeclampsia using thromboelastography. Anesthesiology 1999;90:385–90.
71. Butwick A, Carvalho B. The effect of colloid and crystalloid preloading on thromboelastography prior to Cesarean delivery. Can J Anaesth 2007;54:190–5.
72. Craft RM, Chavez JJ, Bresee SJ, et al. A novel modification of the thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 2004;143:301–9.
73. Carroll RC, Chavez JJ, Snider CC, et al. Correlation of perioperative platelet function and coagulation tests with bleeding after cardiopulmonary bypass surgery. J Lab Clin Med 2006;147:197–204.
74. Hobson AR, Agarwala RA, Swallow RA, et al. Thrombelastography: current clinical applications and its potential role in interventional cardiology. Platelets 2006;17:509–18.
75. Lev EI, Ramchandani M, Garg R, et al. Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery. J Thromb Thrombolysis 2007;24:15–21.
76. Despotis GJ, Santoro SA, Spitznagel E, Kater KM, et al. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1994;107:271–9.
77. Despotis GJ, Goodnough LT. Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery. Ann Thorac Surg 2000;70:S20–S32.
78. Shore-Lesserson L, Manspeizer H, DePerlo M, et al. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999;88:312–9.
79. Avidan MS, Alcock EL, Da Fonseca J, Ponte J, et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004;92:178–86.
80. Capraro L, Kuitunen A, Salmenpera M, Kekomaki R. On-site coagulation monitoring does not affect hemostatic outcome after cardiac surgery. Acta Anaethesiol Scand 2001;45:200–6.
81. Steiner ME, Despotis GJ. Transfusion algorithms and how they apply to blood conservation: the high-risk cardiac surgical patient. Hematol Oncol Clin North Am 2007;21:177–84.